Subcutaneous Immunotherapies in Solid Tumors: Are We Truly Expanding Access and Efficiency?
SC immunotherapy reduces chair time from 5-7 hours to 7 minutes but faces 45% reimbursement reduction and higher drug dose requirements.


No posts found in this category.

We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
These cookies are needed for adding comments on this website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.